These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evidence for, and localization of, a unitary dopamine receptor composed of cooperatively linked subunit binding sites in rat striatum. Leysen JE, Gommeren W, Laduron PM. Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):312-4. PubMed ID: 543764 [No Abstract] [Full Text] [Related]
3. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor. Leff SE, Creese I. Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067 [Abstract] [Full Text] [Related]
4. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol. Hancock AA, Marsh CL. Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230 [Abstract] [Full Text] [Related]
5. Alterations in dopamine receptors: effect of lesion and haloperidol treatment. Goldstein M, Lew JY, Asano T, Ueta K. Commun Psychopharmacol; 1980 Nov; 4(1):21-5. PubMed ID: 6105037 [No Abstract] [Full Text] [Related]
6. Binding of [3H]apomorphine to striatal membranes prepared from rat brain after 6-hydroxydopamine and kainic acid lesions. Fujita N, Saito K, Iwatsubo K, Hirata A, Noguchi Y, Yoshida H. Brain Res; 1980 May 26; 190(2):593-6. PubMed ID: 7370810 [No Abstract] [Full Text] [Related]
7. Guanine nucleotides distinguish between two dopamine receptors. Creese I, Usdin T, Snyder SH. Nature; 1979 Apr 05; 278(5704):577-8. PubMed ID: 431724 [No Abstract] [Full Text] [Related]
8. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol. Schweitzer JW, Schwartz R, Friedhoff AJ. Res Commun Chem Pathol Pharmacol; 1982 Oct 05; 38(1):21-30. PubMed ID: 7146618 [Abstract] [Full Text] [Related]
9. Effect of kainic acid on striatal dopamine receptors. Weinreich P, Seeman P. Brain Res; 1980 Oct 06; 198(2):491-6. PubMed ID: 7407614 [No Abstract] [Full Text] [Related]
10. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment. MacKenzie RG, Zigmond MJ. J Neurochem; 1984 Nov 06; 43(5):1310-8. PubMed ID: 6208330 [Abstract] [Full Text] [Related]
11. Aging and the regulation of striatal dopaminergic mechanisms in mice. Randall PK, Severson JA, Finch CE. J Pharmacol Exp Ther; 1981 Dec 06; 219(3):695-700. PubMed ID: 7197719 [Abstract] [Full Text] [Related]
18. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system]. Zharkovskiĭ AM, Nurk AM. Fiziol Zh SSSR Im I M Sechenova; 1981 Nov 06; 67(11):1606-10. PubMed ID: 6799331 [Abstract] [Full Text] [Related]
19. Localization of dopamine receptors in rat brain. Reisine TD, Nagy JI, Fibiger HC, Yamamura HI. Brain Res; 1979 Jun 15; 169(1):209-14. PubMed ID: 455093 [No Abstract] [Full Text] [Related]
20. Reversible decrease in dopaminergic 3H-agonist binding after 6-hydroxydopamine and irreversible decrease after kainic acid. Schweitzer BI, Bacopoulos NG. Life Sci; 1983 Jan 31; 32(5):531-40. PubMed ID: 6296593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]